Heat Biologics Appoints Timothy Creech as Chief Financial

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Heat Biologics Appoints Timothy Creech as Chief Financial Officer

DURHAM, N.C., Dec. 1, 2015 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. ("Heat") (Nasdaq: HTBX ), an immuno-oncology company developing novel therapies that activate a patient's immune system against cancer, announced the appointment of Timothy Creech as Heat's new Chief Financial Officer.

"With over 30 years of experience in pharmaceutical and biotechnology management, Tim is well-versed in the financial and reporting challenges facing high-growth biotechnology companies. He also brings expertise in strategic partnerships and the development and commercialization of pharmaceutical products," said Jeff Wolf, Heat's Chief Executive Officer. "Tim will be a valuable addition to our leadership team and we look forward to his contributions as we focus on advancing our clinical programs."    

Most recently, Mr. Creech served as Acting CFO of Salix Pharmaceutical, Inc., a publicly-held specialty pharmaceutical company acquired by Valeant for $11 billion in April 2015. Prior to his appointment as Acting CFO for Salix, Mr. Creech held several financial leadership positions at the company over the last seven years including Senior Vice President, Finance and Administrative Services. Before joining Salix in 2007, Mr. Creech served as Vice President of Finance and Chief Accounting Officer at Voyager Pharmaceutical Corporation, a privately held biotechnology company. Mr. Creech also previously spent seven years at Trimeris, Inc., a publicly-listed biotechnology company engaged in the discovery and development of novel therapeutic agents, serving in the role of Vice President of Finance, and Principal Accounting Officer and Secretary.                

Mr. Creech is a certified public accountant (CPA). He received a MBA from the Fuqua School of Business at Duke University and a B.S. in business administration and accounting from the University of North Carolina at Chapel Hill.  

About Heat Biologics, Inc.

Heat Biologics, Inc. (Nasdaq: HTBX ) is an immuno-oncology company developing novel therapies that activate a patient's immune system against cancer. Heat's highly specific T cell-stimulating platform technologies, ImPACT and ComPACT , form the basis of its product candidates. These platforms, in combination with other therapies, such as checkpoint inhibitors, are designed to address three distinct but synergistic mechanisms of action: robust activation of CD8+ "killer" T cells (one of the human immune system's most potent weapons against cancer); T cell co-stimulation to further enhance patients' immune response; and reversal of tumor-induced immune suppression. Currently, Heat is conducting a Phase 2 trial with its HS-410 (vesigenurtacel-L) in patients with non-muscle invasive bladder cancer (NMIBC) and a Phase 1b trial with its HS-110 (viagenpumatucel-L) in combination with an anti-PD-1 checkpoint inhibitor to treat patients with non-small cell lung cancer (NSCLC). 

For more information please visit www.heatbio.com .

Forward Looking Statements

This press release includes forward-looking statements on our current expectations and projections about future events. In some cases forward-looking statements can be identified by terminology such as "may," "should," "potential," "continue," "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions.  These statements are based upon current beliefs, expectations and assumptions and include statements regarding the expected contribution of Mr. Creech and Heat's financial performance, as well as the potential of Heat's ImPACT and ComPACT platform technologies.  These statements are subject to a number of risks and uncertainties, many of which are difficult to predict, including the ability of Heat to successfully integrate new management and Heat's ImPACT and ComPACT therapies to perform as designed, the ability to enroll patients and complete the clinical trials on time, the other factors described in our annual report on Form 10-K for the year ended December 31, 2014 and Heat's other filings with the SEC. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release based on new information, future events, or otherwise, except as required by law.

Heat Biologics, Inc. Jennifer Almond Investor and Media Relations 919-240-7133

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sasol AGM Resolutions Passed in One Swift Swing

Updated Category News Views 44

Sasol's AGM Delivers Smooth Sailing for Shareholders Can't say I'm surprised, but Sasol's annual general meeting on the 13th of November went off without a hitch—unless, of course, you're one of those folks who just loves fireworks at these gatherings. The entire set of resolutions danced through with a resounding "Aye," making it one heck of a day for anyone banking on...

Continue Reading
Elite Robots Expands Global Reach with Mobile Manipulators

Updated Category News Views 48

Robots Hitting the Road? Picture this: robots that aren't just bolted to a factory floor but roam the production lines like tireless workers on wheels. That's what Elite Robots is betting on with their shiny new ELITEMISSION mobile manipulators. Not Just Any Old Robot These bad boys combine a robotic arm with an autonomous mobile platform. Think of an octopus getting off...

Continue Reading
Mercari and Suruga-ya Forge U.S. Venture for Culture

Updated Category News Views 36

Japanese Pop Culture Gears Up for US Market Surge Alright, folks, what we’ve got here is another bold move in the cross-border e-commerce game. Mercari and Suruga-ya are teaming up to establish a joint venture over in the U.S. The goal? To further capitalize on the growing appetite for Japanese entertainment and hobby goods among us all stateside. Now, it’s no secret...

Continue Reading
Carolina Pines Tackles Rural Healthcare Myths on TV

Updated Category News Views 37

Rural Healthcare Battles the Big City Myth Picture this: you're in a tiny town where everyone knows your dog's name, but some think you've got to head to the city for top-notch medical care. That's where Carolina Pines Regional Medical Center steps in. They’ve snagged a spot on 'All Access with Andy Garcia', shining a light on how investments in tech and talent keep...

Continue Reading
Bank Hapoalim's Q3 2026: Steady Growth Amid Challenges

Updated Category News Views 15

Digging Deep into Hapoalim's Recent Results Now ain't this a turn of events? Bank Hapoalim rolls out its numbers for Q3 2026, and while there's no confetti dropping from the ceiling, the numbers are telling their own story. Net profit comes to a solid NIS 2,364 million, but we're looking at a landscape that's not all rose-tinted today. The bank's managed to pull off...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 210

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Sungrow's Keeper Family: Revolutionizing C&I Energy Storage

Updated Category News Views 76

The Next Level in Energy Storage Solutions Well, folks, Sungrow's got something up its sleeve that's shaking up the energy storage scene. They're calling it the 'Keeper Family,' and if you’re deep into commercial and industrial (C&I) energy storage, this might just be your ticket to topping those profit charts. Launched at the Global Energy Pioneer Summit 2026, their...

Continue Reading
Tuya Smart: AI Powers New Energy Wave at COP31

Updated Category News Views 90

Tuya Smart's Bold Move at COP31 Tuya Smart, a name you don't want to ignore in the world of energy innovation, made a commanding appearance at COP31. Their message was loud and clear: as the climate gets harsher, they're not just sitting around waiting for the next storm. They're arming households with AI-driven solutions. AI-Powered Energy Management Takes Center Stage...

Continue Reading
FFR's Michigan Milestone and Major Robotics Update

Updated Category News Views 165

Nobody's going to argue that breaking into new territories isn't a gamble, but sometimes you just need to roll the dice. FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is banking on their move with Aegis Ultra robots, making an academic splash at Central Michigan University. This isn't just about ticking off another state; it's about stacking the deck with new...

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 14

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading

Top 5 Most Recently Viewed Articles

Infosys Partners with Meta to Lead AI Innovations Forward

Updated Category News Views 205

Infosys Enhances Partnership with Meta for AI Advancements Infosys (NSE: INFY, BSE: INFY, NYSE: INFY), a leading player in digital services and consulting, is thrilled to announce an expansion of its collaborative efforts with Meta Platforms, Inc. This partnership is aimed at pioneering new innovations in generative artificial intelligence (AI) by emphasizing open-source...

Continue Reading
Key Stocks to Monitor Midweek: Highlights from the Market

Updated Category News Views 239

Market Overview As the trading day unfolds with U.S. stock futures showing mixed signals, several companies are drawing the attention of investors. This article explores some key stocks to watch this week, highlighting their expected performance and noteworthy developments. Chewy Inc. Earnings Preview Analysts are eager to see how Chewy Inc. (NYSE: CHWY) will perform,...

Continue Reading
AI and Personalized Learning: Shaping Future Education Models

Updated Category News Views 238

AI Meets Education: A Spotlight on Everest Nevraumont In the education arena, some stories demand your attention. One such narrative is that of 11-year-old Everest Nevraumont, a beacon for what modern learning can achieve through the power of artificial intelligence. Recent events around her presence at the 2026 State of the Union address make it clear: this isn't just a...

Continue Reading
Empowering Small Businesses: Mighty and Amazon Collaboration

Updated Category News Views 208

Strengthening the Bond Between Mighty and Amazon Business Recently, Mighty made headlines with the expansion of its Amazon Business In-Person Registration Program, aimed at providing practical onboarding and purchasing assistance to small businesses across North America. The program represents a significant development in how businesses can merge digital tools with...

Continue Reading
ProShares IQQQ ETF: A Strategic Choice for Income Investors

Updated Category News Views 226

Understanding the Current Market Landscape In the ever-evolving financial markets, significant changes can impact investment strategies. Recently, we witnessed noteworthy developments from the Federal Reserve, which adjusted its benchmark interest rate. This shift not only influences investor behavior but also reshapes the landscape for income-seeking individuals....

Continue Reading